Medical-cannabis companies blast New York for ‘clear course for failure’ in state pot-business rollout

대한민국 뉴스 뉴스

Medical-cannabis companies blast New York for ‘clear course for failure’ in state pot-business rollout
대한민국 최근 뉴스,대한민국 헤드 라인

Curaleaf, Green Thumb Industries, PharmaCann and Acreage argue that a proliferation of illegal shops and dangerous products is harming the state.

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

New York state’s largest medical-cannabis companies, which have been barred from wading into the adult-use market for more than two years, are saying they’ve waited long enough for licenses from the state.

While cannabis was legalized in the state more than two years ago, existing medical-pot companies have not been issued any permits, because the state is issuing its first licenses to social-equity applicants under its Conditional Adult-Use Retail Dispensary Program . Such a move could add up to 33 retail cannabis locations to those currently operating in the state and, they said, “provide a dependable supply of safe, tested cannabis products.”

In July, the state’s Office of Cannabis Management approved 212 CAURD licenses, bringing the total number of licenses in the state to 463.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

MarketWatch /  🏆 3. in KR
 

대한민국 최근 뉴스, 대한민국 헤드 라인



Render Time: 2025-01-13 23:24:19